American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Plastic and reconstructive surgery 2024 Vol.154(3) p. 473-483

Clemens MW, Myckatyn TM, Di Napoli A, Feldman AL, Jaffe ES, Haymaker CL, Horwitz SM, Hunt KK, Kadin ME, McCarthy CM, Miranda RN, Prince HM, Santanelli di Pompeo F, Holmes SD, Phillips LG

관련 도메인

Abstract

[BACKGROUND] In the absence of high-quality evidence, there is a need for guidelines and multidisciplinary consensus recommendations on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). The purpose of this expert consensus conference was to evaluate the existing evidence regarding the diagnosis and management of BIA-ALCL caused by textured implants. This article aims to provide evidence-based recommendations regarding the management and prevention of BIA-ALCL.

[METHODS] A comprehensive search was conducted in the MEDLINE, Cochrane Library, and Embase databases, and supplemented by manual searches of relevant English-language articles and "related articles" sections. Studies focusing on breast surgery and lymphoma associated with breast implants were included for analysis. Meta-analyses were performed and reviewed by experts selected by the American Association of Plastic Surgeons using a Delphi consensus method.

[RESULTS] A total of 840 articles published between January of 2011 and January of 2023 were initially identified and screened. The full text of 188 articles was assessed. An additional 43 articles were excluded for focus, and 145 articles were included in the synthesis of results, with 105 of them being case reports or case series. The analysis encompassed a comprehensive examination of the selected articles to determine the incidence, risk factors, clinical presentation, diagnostic approaches, and treatment modalities related to BIA-ALCL.

[CONCLUSIONS] Plastic surgeons should be aware of the elevated risks by implant surface type, implement appropriate patient surveillance, and follow the recommendations outlined in this statement to ensure patient safety and optimize outcomes. Ongoing research on the pathogenesis, genetic drivers, and preventative and prophylactic measures for BIA-ALCL is crucial for improving patient care.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Risk, V.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 bia-alcl 보형물연관 역형성대세포림프종 dict 5
해부 breast 유방 dict 4
약물 [BACKGROUND] scispacy 1
약물 Embase scispacy 1
약물 [RESULTS] A scispacy 1
약물 [CONCLUSIONS] Plastic surgeons should scispacy 1
질환 Breast Implant-Associated Anaplastic Large-Cell Lymphoma C4528210
Breast implant-associated anaplastic large-cell lymphoma
scispacy 1
질환 lymphoma C0024299
Lymphoma
scispacy 1
질환 sections scispacy 1
기타 patient scispacy 1

MeSH Terms

Humans; Lymphoma, Large-Cell, Anaplastic; Breast Implants; Female; Breast Neoplasms; Breast Implantation; United States; Societies, Medical; Risk Factors; Postoperative Complications

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문